014 The Investigational Drug Bremelanotide for Hypoactive Sexual Desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies. (1st February 2018) - Clayton, A.H.; Kingsberg, S.A.; Simon, J.; Jordan, R.; Lucas, J.